Flu Research at Emory
Influenza Pathogenesis & Immunology Research Center
The Influenza Pathogenesis & Immunology Research Center, a joint endeavor of Emory University and the University of Georgia, is one of six national Influenza Centers of Excellence funded by NIH/NIAID. The center's scientists study all the factors that influence the emergence, transmission and pathogencity of flu viruses, with the aim of improving diagnosis, prevention and treatment. In the event of a public health emergency involving an influenza pandemic, the national network of flu centers is on the frontline to implement the NIAID Pandemic Public Health Research Response Plan.
- Emory Leads National Human Immunology Center, Funded by $16 Million NIH Grant / Aug. 12, 2009
- Emory/UGA Flu Center Helps Lead National H1N1 Research Response / May 5, 2009
Emory Vaccine Center
The Emory Vaccine Center was founded in 1996 to develop vaccines against chronic and infectious diseases. With 35 scientists plus over 200 graduate students and research staff, Emory's vaccine center is one of the largest, most comprehensive and most successful in the world.
H1N1 Clinical Trials
Emory University, as one of eight members of the NIH-supported Vaccine Treatment and Evaluation Units, is conducting clinical trials testing new H1N1 flu vaccines in adults and children.
- Pediatric H1N1 Vaccine Clinical Trial Opens at Emory - Children's Center - Aug. 28, 2009
- Emory Begins Vaccinating Volunteers Today in First H1N1 Clinical Trial / Aug. 10, 2009
- Emory Participates in H1N1 Clinical Trials / July 22, 2009
"Safeguarding Against Flu"
(2 min. 1 sec.)
"Details of Pediatric H1N1 Vaccine Clinical Trial"
(1 min. 5 sec.)
Sound Science
Listen to Emory Vaccine Director Rafi Ahmed describe the new method he and his colleagues are developing to use monoclonal antibodies for rapid flu diagnosis and treatment.
